Published in J Biomed Mater Res A on March 30, 2015
Lamin A/C deficiency reduces circulating tumor cell resistance to fluid shear stress. Am J Physiol Cell Physiol (2015) 0.77
Enhanced and Differential Capture of Circulating Tumor Cells from Lung Cancer Patients by Microfluidic Assays Using Aptamer Cocktail. Small (2016) 0.76
Circulating Tumor Cells: When a Solid Tumor Meets a Fluid Microenvironment. Adv Exp Med Biol (2016) 0.75
Polymeric mechanical amplifiers of immune cytokine-mediated apoptosis. Nat Commun (2017) 0.75
Inflammation and cancer. Nature (2002) 53.78
Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature (2007) 19.33
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res (2004) 14.53
A perspective on cancer cell metastasis. Science (2011) 13.31
WSXM: a software for scanning probe microscopy and a tool for nanotechnology. Rev Sci Instrum (2007) 12.45
Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science (2013) 10.87
Circulating tumor cells: approaches to isolation and characterization. J Cell Biol (2011) 6.54
Adhesion through L-selectin requires a threshold hydrodynamic shear. Nature (1996) 4.19
Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood. Proc Natl Acad Sci U S A (2000) 3.16
Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer. J Oncol (2009) 3.14
Infectious susceptibility and severe deficiency of leukocyte rolling and recruitment in E-selectin and P-selectin double mutant mice. J Exp Med (1996) 3.04
Neutrophils roll on E-selectin. J Immunol (1993) 2.91
Review: Biological relevance of disseminated tumor cells in cancer patients. Int J Cancer (2008) 2.72
Quantitation of cell shedding into efferent blood of mammary adenocarcinoma. Cancer Res (1975) 2.49
The identification and characterization of breast cancer CTCs competent for brain metastasis. Sci Transl Med (2013) 2.18
Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation (1996) 2.05
Circulating tumor cells: a window into cancer biology and metastasis. Curr Opin Genet Dev (2010) 2.03
Microtube device for selectin-mediated capture of viable circulating tumor cells from blood. Clin Chem (2012) 1.97
Sensitive capture of circulating tumour cells by functionalized graphene oxide nanosheets. Nat Nanotechnol (2013) 1.92
E-selectin supports neutrophil rolling in vitro under conditions of flow. J Clin Invest (1993) 1.90
Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. Nat Nanotechnol (2012) 1.85
Glycosaminoglycan synthesis by cultured human skin fibroblasts after transformation with simian virus 40. J Biol Chem (1977) 1.77
Systemic inflammation increases cancer cell adhesion to hepatic sinusoids by neutrophil mediated mechanisms. Int J Cancer (2009) 1.72
Halloysite clay nanotubes for controlled release of protective agents. ACS Nano (2008) 1.38
TRAIL-coated leukocytes that kill cancer cells in the circulation. Proc Natl Acad Sci U S A (2014) 1.31
Distributions of wall shear stress in venular convergences of mouse cremaster muscle. Microcirculation (2003) 1.25
MUC1 mediates transendothelial migration in vitro by ligating endothelial cell ICAM-1. Clin Exp Metastasis (2005) 1.23
Dendrimer-mediated multivalent binding for the enhanced capture of tumor cells. Angew Chem Int Ed Engl (2011) 1.22
A disaccharide precursor of sialyl Lewis X inhibits metastatic potential of tumor cells. Cancer Res (2003) 1.16
Delivery of apoptotic signal to rolling cancer cells: a novel biomimetic technique using immobilized TRAIL and E-selectin. Biotechnol Bioeng (2009) 1.11
Altered hyaluronan biosynthesis in cancer progression. Semin Cancer Biol (2008) 1.09
Nanoroughened surfaces for efficient capture of circulating tumor cells without using capture antibodies. ACS Nano (2012) 1.08
Use of naturally occurring halloysite nanotubes for enhanced capture of flowing cells. Langmuir (2010) 1.06
Nanobiotechnology for the capture and manipulation of circulating tumor cells. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2011) 1.06
P-Selectin coated microtube for enrichment of CD34+ hematopoietic stem and progenitor cells from human bone marrow. Clin Chem (2007) 1.04
Isolation and molecular characterization of circulating melanoma cells. Cell Rep (2014) 1.02
Direct measurements on CD24-mediated rolling of human breast cancer MCF-7 cells on E-selectin. Anal Chem (2011) 1.01
Knockdown of fucosyltransferase III disrupts the adhesion of circulating cancer cells to E-selectin without affecting hematopoietic cell adhesion. Carbohydr Res (2010) 1.00
Fluid Shear Stress Sensitizes Cancer Cells to Receptor-Mediated Apoptosis via Trimeric Death Receptors. New J Phys (2013) 0.99
E-selectin liposomal and nanotube-targeted delivery of doxorubicin to circulating tumor cells. J Control Release (2012) 0.97
Circulating tumor cells: the substrate of personalized medicine? Front Oncol (2012) 0.97
Clinicopathological implications of EpCAM expression in adenocarcinoma of the lung. Anticancer Res (2009) 0.97
Expression patterns of alpha 2,3-sialyltransferases and alpha 1,3-fucosyltransferases determine the mode of sialyl Lewis X inhibition by disaccharide decoys. J Biol Chem (2003) 0.95
Computational and experimental models of cancer cell response to fluid shear stress. Front Oncol (2013) 0.95
Rapid isolation of viable circulating tumor cells from patient blood samples. J Vis Exp (2012) 0.93
Expression of E-selectin ligands on circulating tumor cells: cross-regulation with cancer stem cell regulatory pathways? Front Oncol (2012) 0.93
In vivo tumor cell adhesion in the pulmonary microvasculature is exclusively mediated by tumor cell--endothelial cell interaction. BMC Cancer (2010) 0.92
Shear-induced resistance to neutrophil activation via the formyl peptide receptor. Biophys J (2012) 0.91
Physical biology in cancer. 3. The role of cell glycocalyx in vascular transport of circulating tumor cells. Am J Physiol Cell Physiol (2013) 0.90
Nanostructured Surfaces to Target and Kill Circulating Tumor Cells While Repelling Leukocytes. J Nanomater (2012) 0.90
Role of c-Abl in L-selectin shedding from the neutrophil surface. Blood Cells Mol Dis (2011) 0.89
Enlargement of halloysite clay nanotube lumen by selective etching of aluminum oxide. ACS Nano (2012) 0.89
P-selectin-mediated platelet activation promotes adhesion of non-small cell lung carcinoma cells on vascular endothelial cells under flow. Mol Med Rep (2012) 0.88
Fluid shear stress increases neutrophil activation via platelet-activating factor. Biophys J (2014) 0.87
Stem cell enrichment with selectin receptors: mimicking the pH environment of trauma. Sensors (Basel) (2013) 0.86
Inducing apoptosis in rolling cancer cells: a combined therapy with aspirin and immobilized TRAIL and E-selectin. Mol Pharm (2012) 0.86
Differential drug responses of circulating tumor cells within patient blood. Cancer Lett (2013) 0.83
Preoperative dietary restriction reduces hepatic tumor load by reduced E-selectin-mediated adhesion in mice. J Surg Oncol (2010) 0.83
Unnatural killer cells to prevent bloodborne metastasis: inspiration from biology and engineering. Expert Rev Anticancer Ther (2014) 0.80
A microfluidic device to select for cells based on chemotactic phenotype. Technology (Singap World Sci) (2014) 0.79